Dosimetric impact of switching from AAA to Acuros dose-to-water and dose-to-medium for RapidArc plans of nasopharyngeal carcinomas.
暂无分享,去创建一个
E. Nasr | J. El Barouky | F. Azoury | T. Felefly | R. Sayah | C. El Khoury | N. Farah | L. Zouein | N. Khater | C. Roukoz | D. Nehmé Nasr